Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02194088 · ClinicalTrials.gov registry record · Phase 3
Combined Medication for Improved Analgesia in Superficial Pain
A Phase 3 study, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- Phase 3
- Development phase
- 100
- Enrollment target
NCT02194088 is a Phase 3 study that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 100 participants.
The verdict
NCT02194088, a Phase 3 study, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 100 participants
- Enrollment target
Study Summary
This research study is being done to assess if a combination of medications can enhance the relief of superficial pain (pain at the surface of the skin, such as sunburn pain). The investigators also want to find out if certain genes may be linked to individual differences in experienced efficacy of pain killers. The combination of medications under investigation is diclofenac and atropine. Diclofenac has been approved by the U.S. Food and Drug Administration (FDA) to treat pain. Atropine has been approved by the FDA to treat certain types of poisoning, heartbeat problems, and other diseases but atropine is not approved to treat pain. However, atropine has been used for many years in different European countries to treat painful conditions such as stomach cramps.This research study will compare diclofenac and atropine to placebo.
Interventions
- DRUG Placebo
- DRUG Diclofenac and Atropine combination drug
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2014-04 |
| Est. Completion | 2017-06 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02194088
The ClinicalTrials.gov registry entry for NCT02194088 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02194088 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02194088 about?
NCT02194088 is a clinical study titled "Combined Medication for Improved Analgesia in Superficial Pain". This research study is being done to assess if a combination of medications can enhance the relief of superficial pain (pain at the surface of the skin, such as sunburn pain). The investigators also want to find out if certain genes may be linked to individual differences in experienced efficacy of ...
What is the current status of trial NCT02194088?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 100 participants. The study started on 2014-04. Estimated completion is 2017-06.
What interventions are being tested in trial NCT02194088?
The interventions under investigation include: Placebo (DRUG), Diclofenac and Atropine combination drug (DRUG).
Who is sponsoring clinical trial NCT02194088?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.